Alliance A011203: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer
      Google Scholar   
Citation:
Cancer Res vol 80 (4 Supplement) Abstract PD7-06
Meeting Instance:
SABCS 2019
Year:
2020
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, U10CA180820 (ECOG-ACRIN)  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-TX035   
Study
Alliance-A011203
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: